Achillion Pharma (ACHN) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mail
Get Alerts ACHN Hot Sheet
Price: $0.79 --0%
Financial Fact:
Research and development: 16.7M
Today's EPS Names:
HOVR, VFS, PGR, More
Financial Fact:
Research and development: 16.7M
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Achillion Pharma (NASDAQ: ACHN) reported Q2 EPS of ($0.16), in-line with the analyst estimate of ($0.16).
For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- Neogen Corp. (NEOG) Tops Q1 EPS by 3c; raises guidance
- Lamb Weston (LW) Tops Q1 EPS by 15c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
